<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-molecules-25-04435">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cao</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial–Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling</article-title>
  <source>Front. Pharmacol.</source>
  <year>2019</year>
  <fpage>9</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2018.01525</pub-id>
  <?supplied-pmid 30670971?>
  <pub-id pub-id-type="pmid">30837865</pub-id>
 </element-citation>
</ref>
